Kruse Bo 4
4 · Y-mAbs Therapeutics, Inc. · Filed Dec 7, 2021
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Sale
Common Stock
2021-12-06$16.35/sh−4,000$65,400→ 201,077 total
Footnotes (1)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.